 HINGHAM, Mass., Nov. 17, 2020 GLOBE NEWSWIRE -- Microbot Medical Inc. Nasdaq: MBOT announced that it has received patents in multiple jurisdictions, further demonstrating the Companys continued execution of expanding and protecting its Intellectual Property IP portfolio. The Company now has 40 issuedallowed patents and 23 patent applications pending worldwide. 